These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 118836)

  • 1. Monomeric (7S) IgM in chronic liver disease.
    Fakunle YM; Aranguibel F; de Villiers D; Thomas HC; Sherlock S
    Clin Exp Immunol; 1979 Nov; 38(2):204-10. PubMed ID: 118836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomeric (7S) IgM in primary biliary cirrhosis.
    Taal BG; Schalm SW; de Bruyn AM; Kornman-vd Bosch HJ
    Scand J Gastroenterol; 1982 Mar; 17(2):173-5. PubMed ID: 6813951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of C3b-binding in chronic liver diseases.
    Hautanen A; Salaspuro MP
    Scand J Gastroenterol; 1981; 16(4):505-12. PubMed ID: 7323688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies and serum immunoglobulins in chronic liver diseases.
    Ladefoged K; Andersen P; Jørgensen J
    Acta Med Scand; 1979; 205(1-2):103-9. PubMed ID: 310633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight (7s) immunoglobulin M antibody against hepatitis B core antigen in the serum for differentiating acute from persistent hepatitis B virus infection.
    Tsuda F; Naito S; Takai E; Akahane Y; Furuta S; Miyakawa Y; Mayumi M
    Gastroenterology; 1984 Jul; 87(1):159-64. PubMed ID: 6724259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties.
    Lindgren S; Eriksson S
    J Lab Clin Med; 1982 May; 99(5):636-45. PubMed ID: 7069268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary studies on the detection, isolation and partial characterization of Clq-containing IgM immune complexes in sera of patients with primary biliary cirrhosis.
    Willson RA; Balint J
    Immunol Lett; 1988 Apr; 17(4):303-9. PubMed ID: 3259541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer.
    Coursaget P; Barres JL; Tortey E; Cotty P; Diop T; Yvonnet B; Sow MT; Mboup S; Diop B; Bocande JE
    Cancer Res; 1986 Mar; 46(3):1492-4. PubMed ID: 3943106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monomeric igM in acute and chronic liver diseases (author's transl)].
    Schwarz JA; Kaboth U; Reikowski H; Jost H; Müting D; Ortmanns H
    Klin Wochenschr; 1975 Jun; 53(11):535-8. PubMed ID: 807770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single step radial immunodiffusion (RID) method for the quantitation of monomeric IgM.
    Coughlan RJ; Faith A; Panayi GS; Unger A; Amlot P
    J Clin Lab Immunol; 1984 Sep; 15(1):51-4. PubMed ID: 6439870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles of serum complement in patients with hepatobiliary diseases.
    Potter BJ; Elias E; Fayers PM; Jones EA
    Digestion; 1978; 18(5-6):371-83. PubMed ID: 86474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monomeric IgM in lymphoproliferative, autoimmune and infectious diseases in man (author's transl)].
    Schwarz JA
    Immun Infekt; 1977 Feb; 5(1):23-9. PubMed ID: 403125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low molecular weight (7S) IgM and free light chains in the sera of patients with the tropical splenomegaly syndrome.
    Fakunle YM; Greenwood BM
    Clin Exp Immunol; 1977 Apr; 28(1):153-6. PubMed ID: 405168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE; Steward MW; Viola L; Howard CR; Murray-Lyon IM
    Immunology; 1983 Aug; 49(4):673-83. PubMed ID: 6307866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue localization of Australia antigen immune complexes in acute and chronic hepatitis and liver cirrhosis.
    Nowoslawski A; Krawczyński K; Brzosko WJ; Madaliński K
    Am J Pathol; 1972 Jul; 68(1):31-56. PubMed ID: 4628111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation and evaluation of low molecular weight IgM in rheumatoid arthritis.
    Roberts-Thomson PJ; Neoh SH; Bradley J
    Ann Rheum Dis; 1980 Aug; 39(4):349-53. PubMed ID: 6893651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.
    Jaffe CJ; Vierling JM; Jones EA; Lawley TJ; Frank MM
    J Clin Invest; 1978 Nov; 62(5):1069-77. PubMed ID: 711852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation in chronic liver disease.
    Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
    Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J; Vodák M; Zichová M
    Acta Virol; 1993; 37(2-3):170-4. PubMed ID: 8105661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement metabolism in chronic liver disease: catabolism of C1q in chronic active liver disease and primary biliary cirrhosis.
    Potter BJ; Elias E; Thomas HC; Sherlock S
    Gastroenterology; 1980 May; 78(5 Pt 1):1034-40. PubMed ID: 7380176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.